Who owns HEMAB THERAPEUTICS HOLDINGS?
- CUSIP Number: 423494103
Tip: Access positions for across all investors
Analyze quarterly positions in Hemab Therapeutics Holdings with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Hemab Therapeutics Holdings stock
Who bought or sold HEMAB THERAPEUTICS HOLDINGS this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 7.8M | $287M | 100% | Jun 2026 |
|
| Novo A/S | 4.2M | $154M | 100% | Jun 2026 |
|
| FMR | 3.7M | $136M | 100% | Jun 2026 |
|
| Capital Research and Management Company - Division 3 | 3.6M | $132M | 100% | Jun 2026 |
|
| Deep Track Capital | 3.6M | $132M | 100% | Jun 2026 |
|
| Siren | 2.1M | $77M | 100% | Jun 2026 |
|
| venBio Select Advisor | 1.9M | $71M | 100% | Jun 2026 |
|
| Bain Capital Life Sciences Investors | 1.7M | $61M | 100% | Jun 2026 |
|
| Jpmorgan Chase & Co | 1.2M | $42M | 100% | Jun 2026 |
|
| Vanguard Capital Management | 781k | $29M | 100% | Jun 2026 |
|
| Driehaus Capital Management | 716k | $26M | 100% | Jun 2026 |
|
| Rock Springs Capital Management | 575k | $21M | 100% | Jun 2026 |
|
| Bellevue Group | 550k | $20M | 100% | Jun 2026 |
|
| Citadel Advisors | 524k | $19M | 100% | Jun 2026 |
|
| BlackRock | 284k | $10M | 100% | Jun 2026 |
|
| Deerfield Management Company | 275k | $10M | 100% | Jun 2026 |
|
| ExodusPoint Capital Management | 218k | $8.0M | 100% | Jun 2026 |
|
| Geode Capital Management | 212k | $7.8M | 100% | Jun 2026 |
|
| Braidwell | 160k | $5.9M | 100% | Jun 2026 |
|
| Marshall Wace | 155k | $5.7M | 100% | Jun 2026 |
|
| Woodline Partners | 150k | $5.5M | 100% | Jun 2026 |
|
| Affinity Asset Advisors | 138k | $5.1M | 100% | Jun 2026 |
|
| Ensign Peak Advisors | 115k | $4.2M | 100% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 113k | $4.1M | 100% | Jun 2026 |
|
| Sixth Street Partners Management Company | 108k | $4.0M | 100% | Jun 2026 |
|
| Charles Schwab Investment Management | 108k | $4.0M | 100% | Jun 2026 |
|
| Ameriprise Financial | 82k | $3.0M | 100% | Jun 2026 |
|
| Burkehill Global Management | 75k | $2.8M | 100% | Jun 2026 |
|
| Standard Life Aberdeen | 52k | $1.9M | 100% | Jun 2026 |
|
| Opaleye Management | 48k | $1.8M | 100% | Jun 2026 |
|
| UBS Group | 47k | $1.7M | 100% | Jun 2026 |
|
| Parkman Healthcare Partners | 45k | $1.7M | 100% | Jun 2026 |
|
| Northern Trust | 41k | $1.5M | 100% | Jun 2026 |
|
| Ghisallo Capital Management | 40k | $1.5M | 100% | Jun 2026 |
|
| TD Asset Management | 33k | $1.2M | 100% | Jun 2026 |
|
| Seven Grand Managers | 30k | $1.1M | 100% | Jun 2026 |
|
| Soros Fund Management | 25k | $918k | 100% | Jun 2026 |
|
| Manufacturers Life Insurance Company | 19k | $688k | 100% | Jun 2026 |
|
| GSA Capital Partners | 18k | $649k | 100% | Jun 2026 |
|
| XTX Topco | 17k | $639k | 100% | Jun 2026 |
|
| Landscape Capital Management | 13k | $484k | 100% | Jun 2026 |
|
| Hudson Bay Capital Management | 12k | $448k | 100% | Jun 2026 |
|
| Schonfeld Strategic Advisors | 11k | $397k | 100% | Jun 2026 |
|
| Weiss Asset Management LP[1 | 10k | $367k | 100% | Jun 2026 |
|
| Vanguard Portfolio Management | 8.2k | $300k | 100% | Jun 2026 |
|
| Vanguard Global Advisers | 7.6k | $280k | 100% | Jun 2026 |
|
| Squarepoint Ops | 6.3k | $230k | 100% | Jun 2026 |
|
| Two Sigma Investments | 5.7k | $209k | 100% | Jun 2026 |
|
| China Universal Asset Management | 3.6k | $132k | 100% | Jun 2026 |
|
| Barclays | 1.0k | $37k | 100% | Jun 2026 |
|
| Royal Bank of Canada | 248.00 | $9.0k | 100% | Jun 2026 |
|
| Jones Financial Companies, L.L | 3.00 | $96.999900 | 100% | Jun 2026 |
|
| Tower Research Capital | 1.00 | $37.000000 | 100% | Jun 2026 |
|